Benjamin F. Edwards & Company’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-700	Closed	–	–	1433
2016 Q4	$0	Buy	+700	New	+$834	﹤0.01%	1304

Other funds holding PARN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Benjamin F. Edwards & Company's PARN Position: Q1 2017 in Review

Benjamin F. Edwards & Company sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 700 shares.

Benjamin F. Edwards & Company first reported a position in PARN in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

Benjamin F. Edwards & Company reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
Benjamin F. Edwards & Company sold 700 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017.
Benjamin F. Edwards & Company first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q4 2016 and held it in 1 quarter.
Benjamin F. Edwards & Company's Parnell Pharmaceuticals Holdings Ltd position peaked at $0 in Q4 2016.
2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2017, filed 4 May 2017.